Skip to main content

Table 1 Sociodemographic and clinical characteristics of HIV-positive individuals, by cohort

From: Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study

Parameter

Overall

(n = 198)

WIHS

(n = 111)

MACS

(n = 87)

Age,y

48 (41, 54)

46 (40, 53)

49 (44, 56)

Race/ethnicity

 Black

126 (64)

87 (78)

39 (45)

 White

59 (30)

15 (14)

44 (50)

 Other

13 (6)

9 (8)

4 (5)

 Hispanic

29 (15)

20 (18)

9 (10)

Smoking

 Current

73 (37)

46 (41)

27 (31)

 Past

62 (31)

25 (23)

37 (43)

 Never

62 (31)

40 (36)

22 (26)

 Diabetes mellitus

32 (17)

20 (18)

12 (17)

 Systolic BP, mmHg

126 (114, 137)

121 (110, 134)

129 (117, 137)

 Diastolic BP, mmHg

77 (71, 86)

74 (69, 85)

80 (72, 87)

 Hypertension

93 (48)

56 (50)

37 (44)

 Antihypertensive use

70 (35)

45 (41)

25 (29)

 Statin use

31 (16)

17 (15)

14 (17)

 History of CVD

13 (7)

4 (4)

9 (10)

 BMI, kg/m2

27 (23, 32)

29 (24, 34)

25 (23, 28)

 Waist Circumference, cm

94 (83, 104)

96 (82, 106)

92 (84, 102)

 Current HAART

66 (33)

31 (28)

35 (40)

 Current NRTI

67 (34)

31 (28)

36 (41)

 Current NNRTI

34 (17)

13 (12)

21 (24)

 Current PI

30 (15)

14 (13)

16 (18)

 Current CD4+ count, cells/mm3

483 (338, 682)

485 (314, 667)

465 (387, 716)

 History of AIDS

26 (13)

23 (21)

3 (3)

 Current HIV RNA, <  80 copies/mL

56 (29)

24 (22)

32 (37)

 Hepatitis C virus seropositive

33 (17)

20 (18)

13 (15)

 Estimated GFR

103 (88, 116)

103 (85, 117)

104 (92, 116)

 ACR,mg/g

3.2 (1.9, 7.1)

3.5 (2.0, 12.0)

3.0 (1.8, 5.7)

  1. Data are presented as Median (IQR) or numbers (percent). WIHS Women’s Interagency HIV Study, MACS Multicenter AIDS Cohort Study, BP Blood pressure, CVD Cardiovascular disease, BMI Body Mass Index, HAART Highly active antiretroviral therapy, NRTI Nucleoside Reverse Transcriptase Inhibitors, NNRTI Non-Nucleoside Reverse Transcriptase Inhibitors, PI Protease inhibitors, GFR Glomerular filtration rate, ACR albumin to creatinine ratio